nach oben

Erschienen in:

01.09.2014 | Main topic

Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome

verfasst von: C. Puelacher, P. Hillinger, M. Wagener, Prof. C. Müller

Erschienen in: Herz | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

The acute coronary syndrome (ACS) represents a diagnostic challenge: on the one hand patients need to be quickly identified to initiate treatment and on the other hand early exclusion of patients without ACS is important to relieve patient stress as well as overcrowded emergency departments. A growing number of biomarkers are becoming available to aid physicians with this task. This review gives an overview of the current research concerning early exclusion with an emphasis on the clinically most important biomarker: cardiac troponin.

WHO (2011) WHO | Global status report on noncommunicable diseases 2010. World Health Organization, Geneva

Rosamond W, Flegal K, Friday G et al (2007) Heart disease and stroke statistics 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115:e69–e171PubMedCrossRef

Mockel M, Searle J, Muller R et al (2013) Chief complaints in medical emergencies: do they relate to underlying disease and outcome? The Charité Emergency Medicine Study (CHARITEM). Eur J Emerg Med 20:103–108PubMedCrossRef

Kontos MC, Diercks DB, Kirk JD (2010) Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc 85:284–299PubMedCrossRefPubMedCentral

Anderson JL, Adams CD, Antman EM et al (2011) 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Tas. Circulation 123:e426–e579PubMedCrossRef

Kontos MC, Roberts BD, Tatum JL et al (2009) Mortality based on the presenting electrocardiogram in patients with myocardial infarction in the troponin era. Am J Emerg Med 27:146–152PubMedCrossRef

Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60:1581–1598PubMedCrossRef

Braunwald E, Morrow DA (2013) Unstable angina: is it time for a requiem? Circulation 127:2452–2457PubMedCrossRef

Galińska-Rakoczy A, Engel P, Xu C et al (2008) Structural basis for the regulation of muscle contraction by troponin and tropomyosin. J Mol Biol 379:929–935PubMedCrossRefPubMedCentral

10.

Mueller C (2013) Biomarkers and acute coronary syndromes: an update. Eur Heart J 35:552–556PubMedCrossRef

11.

Thygesen K, Mair J, Katus H et al (2010) Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J 31:2197–2204PubMedCrossRef

12.

Rahman A, Broadley SA (2014) Review article: elevated troponin: diagnostic gold or fool’s gold? Emerg Med Australas 26:125–130PubMedCrossRef

13.

Kelley WE, Januzzi JL, Christenson RH (2009) Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 55:2098–2112PubMedCrossRef

14.

Goodacre S, Thokala P, Carroll C et al (2013) Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. Health Technol Assess 17:v–vi, 1–188

15.

Goodacre S, Cross E, Arnold J et al (2005) The health care burden of acute chest pain. Heart 91:229–230PubMedCrossRefPubMedCentral

16.

Pines JM, Hilton JA, Weber EJ et al (2011) International perspectives on emergency department crowding. Acad Emerg Med 18:1358–1370PubMedCrossRef

17.

Hamm CW, Bassand J-P, Agewall S et al (2011) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999–3054PubMedCrossRef

18.

Cullen L, Mueller C, Parsonage WA et al (2013) Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol 62:1242–1249PubMedCrossRef

19.

Reichlin T, Schindler C, Drexler B et al (2012) One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 172:1211–1218PubMedCrossRef

20.

Goodacre SW, Bradburn M, Cross E et al (2011) The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department. Heart 97:190–196PubMedCrossRef

21.

Morgenthaler NG (2010) Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail 16(Suppl 1):S37–S44PubMedCrossRef

22.

Morgenthaler NG, Struck J, Jochberger S, Dünser MW (2008) Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab 19:43–49PubMedCrossRef

23.

Lippi G, Plebani M, Di Somma S et al (2012) Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin. Clin Chem Lab Med 50:243–253PubMed

24.

Keller T, Tzikas S, Zeller T et al (2010) Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 55:2096–2106PubMedCrossRef

25.

Raskovalova T, Twerenbold R, Collinson PO et al (2014) Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. Eur Hear J Acute Cardiovasc care 3:18–27CrossRef

26.

Möckel M, Searle J, Hamm C et al (2014) Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J (in press)

27.

Carroll C, Al Khalaf M, Stevens JW et al (2013) Heart-type fatty acid binding protein as an early marker for myocardial infarction: systematic review and meta-analysis. Emerg Med J 30:280–286PubMedCrossRef

28.

Reiter M, Twerenbold R, Reichlin T et al (2013) Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction. Heart 99:708–714PubMedCrossRef

29.

Kagawa Y, Toyofuku M, Masaoka Y et al (2013) Comparison of heart-type fatty acid binding protein and sensitive troponin for the diagnosis of early acute myocardial infarction. Int J Cardiol 166:347–351PubMedCrossRef

30.

Scirica BM, Kadakia MB, Lemos JA de et al (2013) Association between natriuretic peptides and mortality among patients admitted with myocardial infarction: a report from the ACTION Registry(R)-GWTG™. Clin Chem 59:1205–1214PubMedCrossRef

31.

Haaf P, Reichlin T, Corson N et al (2011) B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain. Am J Med 124:444–452PubMedCrossRef

32.

Kuwahara K, Kinoshita H, Kuwabara Y et al (2010) Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol Cell Biol 30:4134–4148PubMedCrossRefPubMedCentral

33.

Arjamaa O (2014) Physiology of natriuretic peptides: the volume overload hypothesis revisited. World J Cardiol 6:4–7PubMedCrossRefPubMedCentral

34.

O’Malley RG, Bonaca MP, Scirica BM et al (2014) Prognostic performance of multiple biomarkers in patients with Non-ST elevation acute coronary syndrome: analysis from MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes - Thrombolysis In Myocardial Infarction 36). J Am Coll Cardiol 63(16):1644-1653CrossRef

35.

Klip IT, Voors AA, Anker SD et al (2011) Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction. Heart 97:892–898PubMedCrossRef

36.

Khan SQ, O’Brien RJ, Struck J et al (2007) Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 49:1525–1532PubMedCrossRef

37.

Eitel I, Blase P, Adams V et al (2011) Growth-differentiation factor 15 as predictor of mortality in acute reperfused ST-elevation myocardial infarction: insights from cardiovascular magnetic resonance. Heart 97:632–640PubMedCrossRef

38.

Widera C, Pencina MJ, Meisner A et al (2012) Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome. Eur Heart J 33:1095–1104PubMedCrossRefPubMedCentral

39.

Schaub N, Reichlin T, Meune C et al (2012) Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem 58:246–256PubMedCrossRef

40.

Napoli C, Zullo A, Picascia A et al (2013) Recent advances in proteomic technologies applied to cardiovascular disease. J Cell Biochem 114:7–20PubMedCrossRef

Titel: Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome
verfasst von: C. Puelacher
P. Hillinger
M. Wagener
Prof. C. Müller
Publikationsdatum: 01.09.2014
Verlag: Urban & Vogel
Erschienen in: Herz / Ausgabe 6/2014
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-014-4130-1

Neu im Fachgebiet Kardiologie

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Cardiac biomarkers for infarct diagnosis and early exclusion of acute coronary syndrome

Abstract

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2014

Association of epicardial fat thickness with TIMI risk score in NSTEMI/USAP patients

A new echocardiographic parameter of arterial stiffness in end-stage renal disease

Zeitpunkt der invasiven Therapie beim NSTEMI

The role of bilirubin and its protective function against coronary heart disease

Aktuelle Kardiologie

Right coronary artery emerging as a septal branch from the left anterior descending artery

Neu im Fachgebiet Kardiologie

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Parodontalbehandlung verbessert Prognose bei Katheterablation

Update Kardiologie